89bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 51.68 million compared to USD 28.84 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 0.54 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.07 USD | -2.83% | +0.62% | -27.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.75% | 794M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.60% | 22.67B | |
-9.81% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- ETNB Stock
- News 89bio, Inc.
- 89bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024